Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hadas Ofer-Friedman"'
Autor:
Ronit Zaidenstein, Asaf Miller, Ruthy Tal-Jasper, Hadas Ofer-Friedman, Menachem Sklarz, David E. Katz, Tsillia Lazarovitch, Paul R. Lephart, Bethlehem Mengesha, Oran Tzuman, Mor Dadon, Chen Daniel, Jacob Moran-Gilad, Dror Marchaim
Publikováno v:
Microorganisms, Vol 6, Iss 1, p 9 (2018)
It is unknown as to whether other beta-lactams can be used for bloodstream infections (BSI) resulting from Pseudomonas aeruginosa (PA) which are non-susceptible to one or more carbapenem. We conducted a retrospective cohort study at the Assaf Harofeh
Externí odkaz:
https://doaj.org/article/bd7a9522d9dd413f8f1e76a540afb0be
Autor:
Mordechai Dulitzki, Michal J. Simchen, Iris Morag, Roni Zemet, Hadas Ofer Friedman, Micha Baum
Publikováno v:
European journal of obstetrics, gynecology, and reproductive biology. 263
Objectives Antiphospholipid antibodies have been associated with various obstetric complications, including recurrent pregnancy loss, preeclampsia, intrauterine growth restriction, placental insufficiency, and late fetal loss. Despite the amassed bod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2da54509eba8962585b99c8e36bff648
https://pubmed.ncbi.nlm.nih.gov/34167038
https://pubmed.ncbi.nlm.nih.gov/34167038
Autor:
Michal J. Simchen, Mordechai Dulitzki, Hadas Ofer Friedman, Iris Morag, Micha Baum, Roni Zemet
Objective: To evaluate whether early-onset severe preeclampsia prior to 34 weeks’ gestation is clinically different when associated with antiphospholipid antibodies. Design: A retrospective case-control study. Setting: Single university-affiliated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c484dc105b3fdb5745b3d72c8a3b1208
https://doi.org/10.22541/au.159969766.60686699
https://doi.org/10.22541/au.159969766.60686699
Autor:
Dror Marchaim, Menachem Sklarz, Chen Daniel, Asaf Miller, Oran Tzuman, Paul R. Lephart, Hadas Ofer-Friedman, Bethlehem Mengesha, Ronit Zaidenstein, Tsillia Lazarovitch, Mor Dadon, Jacob Moran-Gilad, David E. Katz, Ruthy Tal-Jasper
Publikováno v:
Microorganisms; Volume 6; Issue 1; Pages: 9
Microorganisms
Microorganisms, Vol 6, Iss 1, p 9 (2018)
Microorganisms
Microorganisms, Vol 6, Iss 1, p 9 (2018)
It is unknown as to whether other beta-lactams can be used for bloodstream infections (BSI) resulting from Pseudomonas aeruginosa (PA) which are non-susceptible to one or more carbapenem. We conducted a retrospective cohort study at the Assaf Harofeh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01d1b03e406337fc0c8b6dcb1bf8f530
Publikováno v:
Open Forum Infectious Diseases. 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0b1df902ef0452a2db215db9e8f7fe1
https://doi.org/10.1093/ofid/ofw172.228
https://doi.org/10.1093/ofid/ofw172.228
Autor:
Keren Amity, Ruthy Tal-Jasper, Keith S. Kaye, Tsilia Lazarovitch, Robert A. Bonomo, Dror Marchaim, Christopher Bogan, Ronit Zaidenstein, Tal Azouri, Tamir Kaplansky, Kayoko Hayakawa, Benjamin Ackerman, Joseph R. Coyle, Hadas Ofer-Friedman, Moran Maskit, Federico Perez, Paul R. Lephart
Publikováno v:
Infection control and hospital epidemiology. 36(11)
BACKGROUNDThe pandemic of carbapenem-resistant Enterobacteriaceae (CRE) was primarily due to clonal spread ofblaKPCproducingKlebsiella pneumoniae. Thus, thoroughly studied CRE cohorts have consisted mostly ofK. pneumoniae.OBJECTIVETo conduct an exten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f156f449b2e37b00180b59288f0462f
https://pubmed.ncbi.nlm.nih.gov/26399907
https://pubmed.ncbi.nlm.nih.gov/26399907
Autor:
Amit Tirosh, Pradeep Bathina, Keith S. Kaye, Dror Marchaim, Tamir Kaplansky, Ronit Zaidenstein, Tal Azouri, Hadas Ofer-Friedman, Coral Shefler, Ruthy Tal-Jasper, Sarit Sharma, Moran Maskit, Deepthi Kandipalli, Tsilia Lazarovitch, Shruti Sharma
Publikováno v:
Infection control and hospital epidemiology. 36(8)
A recent, frequently quoted study has suggested that for bloodstream infections (BSIs) due to extended-spectrum β-lactamase–producing Enterobacteriaceae (ESBL) Escherichia coli, treatment with β-lactam/β-lactamase inhibitors (BLBLIs) might be eq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3d79e3f467e57fce8f01b8fe08a89d4
https://pubmed.ncbi.nlm.nih.gov/25990361
https://pubmed.ncbi.nlm.nih.gov/25990361